We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Iceland-based drugmaker Actavis has announced the launch of the prostate drug finasteride in Spain, Portugal and Slovenia, the antidepressant mirtazapine in France and the antiepileptic drug topiramate in Portugal.
Despite two cases of genetically mutated bird flu in Egypt in which the effectiveness of Roche's Tamiflu (oseltamivir phosphate) was moderately reduced, the World Health Organization (WHO) is not changing its recommendation for using the drug because the level of resistance is not yet well established and the virus has not become more easily transmissible between humans.
The U.S. FTC is set to approve a plan proposed by Hospira to acquire Australia-based Mayne Pharma for $2 billion, as long as certain conditions are met, the agency has announced.
Novartis Pharma, a Japanese subsidiary of Novartis, and Mochida Pharmaceutical announced that the two companies have signed a contract to co-promote Novartis' angiotensin receptor blocker (ARB) Diovan (valsartan) in Japan.
The U.N. announced that child mortality due to measles has decreased by 60 percent since 1999, exceeding the U.N.'s goals, thanks to a four-part disease-prevention strategy that includes stringent vaccination.
An analysis of 84 studies by HHS' Agency for Healthcare Research and Quality (AHRQ) found no strong evidence that atypical antipsychotics are effective for many of the off-label uses for which they are commonly prescribed.